Clinical manifestations and management of four children with Pearson syndrome

Manuela Tumino1, Concetta Meli, Piero Farruggia

  • 1Pediatric Hematology and Oncology, University of Catania, Catania, Italy.

Insights

Pearson syndrome, a fatal mitochondrial DNA disorder, often presents with hematological issues in infants. Hematopoietic stem cell transplantation may offer benefits in early stages, despite potential risks like secondary cancers.

Area of Science:

  • Mitochondrial genetics
  • Pediatric hematology
  • Rare genetic disorders

Background:

  • Pearson syndrome is a severe, often fatal, mitochondrial DNA disorder diagnosed in infancy.
  • It is characterized by bone marrow failure and pancreatic dysfunction.
  • Genetic mutations in mitochondrial DNA are the underlying cause.

Observation:

  • This study reports on four pediatric cases of Pearson syndrome presenting with hematological disorders.
  • Three patients experienced fatal outcomes.
  • One patient underwent hematopoietic stem cell transplantation.

Findings:

  • Hematopoietic stem cell transplantation in the affected patient corrected both hematological and non-hematological manifestations, including metabolic acidosis.
  • Despite successful correction of disease symptoms, this patient later succumbed to a secondary malignancy post-transplantation.

Implications:

  • Hematopoietic stem cell transplantation is proposed as a potential therapeutic option for Pearson syndrome, particularly when initiated early.
  • The findings highlight the complex risks and benefits associated with transplantation for this rare mitochondrial disorder.
  • Further research is warranted to optimize transplantation protocols and manage long-term complications.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...